Literature DB >> 24635858

Total lower lip reconstruction with a double mental neurovascular V-Y island advancement flap.

Qi-Gen Fang1, Shuang Shi2, Xu Zhang1, Zhen-Ning Li1, Fa-Yu Liu3, Chang-Fu Sun4.   

Abstract

PURPOSE: To assess the effectiveness of double mental V-Y island advancement flaps for total lower lip reconstructions.
MATERIALS AND METHODS: During a 6-year period, from 2006 to 2012, total lower lip reconstruction was performed in 12 patients using double mental V-Y island advanced flaps. The resulting lip function and superiority of each flap were analyzed. To assess any cosmetic implications, patients were asked to answer the Appearance Domain section from the University of Washington Quality of Life Questionnaire at least 12 months after discharge from the hospital.
RESULTS: All flaps survived completely and no short-term postoperative complications occurred. The mean follow-up time was 34.5 months (range, 15 to 69 months) and there was no recurrence of disease. All patients were capable of consuming a regular oral diet and no patients complained of an inability to eat in a public setting, drooling, or microstomia. The mean preoperative and postoperative open-mouth widths were 4.1 and 3.7 cm, respectively, and the mean reduced open-mouth width was 10%. The intercommissural width varied from 4.6 to 6.8 cm (mean, 5.5 cm). The mean postoperative 2-point discrimination was 11.2 mm (range, 9 to 13 mm). The mean score for the Appearance Domain section was 93.8 (range, 75 to 100).
CONCLUSION: The mental V-Y island advancement flap reconstruction is a reliable procedure for total lower lip reconstruction.
Copyright © 2014 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24635858     DOI: 10.1016/j.joms.2013.12.010

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  1 in total

1.  Management of and risk factors for regional recurrence in upper lip squamous cell carcinoma.

Authors:  Fei Liu; Lei Wang; Shuang Pang; Quancheng Kan
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.